
|Articles|October 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Antimicrobial Use
- Volume 4
- Issue 11 Suppl
Introduction
Author(s)Gary V. Doern, PhD
Advertisement
Articles in this issue
about 27 years ago
Optimizing Antimicrobial Therapy and Emerging Pathogensabout 27 years ago
Participating Facultyabout 27 years ago
Mechanisms and Current Rates of Resistanceabout 27 years ago
Influence of Antibiotics on the Normal Floraabout 27 years ago
Therapeutic Pathways for Antimicrobial Use: General Overviewabout 27 years ago
Therapeutic Pathways for Antimicrobial Use: Pediatric Issuesabout 27 years ago
Pharmacoeconomic Impact of Appropriate Clinical Pathwaysabout 27 years ago
CME QuizNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol
2
Efficacy and Equity With Oral PCSK9s: Ann Marie Navar, MD, PhD
3
Eosinophilia Linked With Immune-Related Adverse Events in NSCLC Treatment
4
Integrating Sotatercept Into PAH Care: Vallerie McLaughlin, MD
5
















































